Related Experiment Video
Updated: Feb 17, 2026
Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier
Published on: April 5, 2017
Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod
Navid Manouchehri1, Omid Mirmosayyeb1, Shervin Badihian1
1Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran; Students' Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Background:
Previous reports of cutaneous neoplastic lesions secondary to Fingolimod treatment among multiple sclerosis patients.
Objective:
Reporting a case of cutaneous large cell lymphoma in a multiple sclerosis patient during Fingolimod treatment.
Method:
Case study.
Result:
Our patient developed CD30+ cutaneous large cell lymphoma two years after initiation of Fingolimod treatment and her symptoms regressed following the cessation of treatment.
Conclusion:
This report indicates that cutaneous lymphoid neoplasms should be considered a possible side effect among patients receiving Fingolimod.